ATE421256T1 - Probiotische zusammensetzung - Google Patents

Probiotische zusammensetzung

Info

Publication number
ATE421256T1
ATE421256T1 AT06025815T AT06025815T ATE421256T1 AT E421256 T1 ATE421256 T1 AT E421256T1 AT 06025815 T AT06025815 T AT 06025815T AT 06025815 T AT06025815 T AT 06025815T AT E421256 T1 ATE421256 T1 AT E421256T1
Authority
AT
Austria
Prior art keywords
probiotic composition
allergy
drinks
mutant
foods
Prior art date
Application number
AT06025815T
Other languages
English (en)
Inventor
Sayo Inoue
Toshio Fujii
Daisuke Fujiwara
Akira Saiki
Minoru Takahashi
Koichiro Yamauchi
Masami Gotou
Satoshi Nishida
Keiji Deuchi
Hideyuki Wakabayashi
Toshihiro Komeda
Original Assignee
Kirin Holdings Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kirin Holdings Kk filed Critical Kirin Holdings Kk
Application granted granted Critical
Publication of ATE421256T1 publication Critical patent/ATE421256T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F3/00—Tea; Tea substitutes; Preparations thereof
    • A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
    • A23F3/166—Addition of, or treatment with, enzymes or microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F3/00—Tea; Tea substitutes; Preparations thereof
    • A23F3/34—Tea substitutes, e.g. matè; Extracts or infusions thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F5/00—Coffee; Coffee substitutes; Preparations thereof
    • A23F5/24—Extraction of coffee; Coffee extracts; Making instant coffee
    • A23F5/246—Addition of, or treatment with, enzymes or microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/169—Plantarum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Tea And Coffee (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT06025815T 2003-03-13 2004-02-27 Probiotische zusammensetzung ATE421256T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003068943 2003-03-13
JP2003354277 2003-10-14

Publications (1)

Publication Number Publication Date
ATE421256T1 true ATE421256T1 (de) 2009-02-15

Family

ID=33421654

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06025815T ATE421256T1 (de) 2003-03-13 2004-02-27 Probiotische zusammensetzung

Country Status (12)

Country Link
US (1) US20060088513A1 (de)
EP (2) EP1759597B1 (de)
JP (3) JP2005139160A (de)
KR (1) KR100908254B1 (de)
CN (1) CN1767839B (de)
AT (1) ATE421256T1 (de)
AU (1) AU2004233658B2 (de)
CA (1) CA2518947A1 (de)
DE (1) DE602004019255D1 (de)
ES (1) ES2320920T3 (de)
TW (1) TWI324068B (de)
WO (1) WO2004096246A1 (de)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7767203B2 (en) 1998-08-07 2010-08-03 Ganeden Biotech, Inc. Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
US6461607B1 (en) 1998-08-24 2002-10-08 Ganeden Biotech, Inc. Probiotic, lactic acid-producing bacteria and uses thereof
EP1759597B1 (de) * 2003-03-13 2009-01-21 Kirin Holdings Kabushiki Kaisha Probiotische Zusammensetzung
EP1790715A4 (de) * 2004-09-10 2007-08-29 Kirin Brewery Verfahren zur stabilisierung der antiallergenen aktivität von milchsäurebakterien gegen hochtemperaturbehandlung, stabilisierte zusammensetzungen sowie lebensmittel und getränke
TW200637908A (en) * 2005-01-04 2006-11-01 Calpis Co Ltd Method for preparation of lactic acid bacterium having anti-allergic activity
CA2599909C (en) 2005-03-03 2014-12-02 Meiji Dairies Corporation Immune function modulating agents
RU2295726C2 (ru) * 2005-03-05 2007-03-20 Жанна Петровна Васнева СПОСОБ ОПРЕДЕЛЕНИЯ СПЕЦИФИЧЕСКОЙ ГИПЕРЧУВСТВИТЕЛЬНОСТИ И ЕЕ ХАРАКТЕРА in vitro
JP2006273783A (ja) * 2005-03-30 2006-10-12 Musashino Seiyaku Kk 掻痒の予防及び／又は治療用組成物
JP2007084533A (ja) * 2005-08-24 2007-04-05 Prima Meat Packers Ltd 免疫応答調節組成物及び該組成物を有効成分とする食品
WO2007052643A1 (ja) * 2005-10-31 2007-05-10 Suntory Limited ワイン発酵もろみ由来の免疫調節作用を有する乳酸菌
AU2007216461B2 (en) * 2006-02-15 2012-08-30 Société des Produits Nestlé S.A. Use of bifidobacterium longum for the prevention and treatment of inflammation
US20070275150A1 (en) * 2006-05-26 2007-11-29 Ciell Michael P Nutritional composition and method of making the same
JP5314421B2 (ja) * 2006-05-31 2013-10-16 株式会社明治 免疫調節活性の高い乳酸菌の培養法
WO2008023663A1 (en) 2006-08-21 2008-02-28 Sapporo Breweries Limited Bacterial strain having anti-allergic activity, and beverage, food and anti-allergic agent comprising cell of the bacterial strain
EP2073643A2 (de) * 2006-10-18 2009-07-01 DSMIP Assets B.V. Verkapselung von hitze- und feuchtigkeitsempfindlichen substanzen
EP1972208A1 (de) * 2007-03-16 2008-09-24 Kirin Holdings Kabushiki Kaisha Zusammensetzung zur Verbesserung der Darmflora
RU2009133376A (ru) * 2007-03-27 2011-05-10 Дзе Проктер Энд Гэмбл Компани (US) Способы и наборы для введения пробиотиков
JP2008245569A (ja) * 2007-03-30 2008-10-16 Kirin Holdings Co Ltd 高抗アレルギー活性を有する乳酸菌組成物及び該乳酸菌の製造方法
CN101677583A (zh) * 2007-06-27 2010-03-24 科.汉森有限公司 用于治疗特应性皮炎的瑞士乳杆菌组合物
SI2211626T1 (sl) 2007-08-29 2019-12-31 Ganeden Biotech, Inc. Pekovski izdelki
JP2009057346A (ja) * 2007-09-03 2009-03-19 Kirin Holdings Co Ltd 免疫バランス調節用組成物
JP2009082126A (ja) * 2007-09-14 2009-04-23 Kikkoman Corp 新規な乳酸菌、それを用いた乳酸発酵物及び乳酸発酵物含有飲食品
HUE054648T2 (hu) * 2007-10-16 2021-09-28 Ganeden Biotech Inc Italkészítmények
JP2009112214A (ja) * 2007-11-02 2009-05-28 Kirin Holdings Co Ltd 乳酸菌含有抗アレルギー用飲料
WO2009066681A1 (ja) 2007-11-19 2009-05-28 Kaneka Corporation 乳酸菌含有製剤
CN101503662B (zh) * 2008-02-05 2011-04-20 光晟生物科技股份有限公司 用于抗过敏症状的微生物株、其组合物和以此微生物株刺激细胞产生干扰素-γ的方法
US8361481B2 (en) 2008-04-25 2013-01-29 Kameda Seika Co., Ltd. Lactic acid bacterium having anti-allergic activity and pharmaceutical composition
US8043645B2 (en) 2008-07-09 2011-10-25 Starbucks Corporation Method of making beverages with enhanced flavors and aromas
FR2938437B1 (fr) * 2008-11-19 2020-03-27 Société des Produits Nestlé S.A. Utilisation cosmetique de microorganisme pour le traitement des peaux grasses
BRPI0919651A2 (pt) 2008-10-16 2015-08-18 Ganeden Biotech Inc Composições probióticas á base de grãos
KR101075557B1 (ko) * 2008-12-03 2011-10-20 씨제이제일제당 (주) 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물
EP2424550B1 (de) 2009-04-29 2017-06-07 Ganeden Biotech, Inc. Bakterienzellmembran formulierung
KR101255050B1 (ko) * 2009-07-14 2013-04-16 씨제이제일제당 (주) 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물
KR101486999B1 (ko) * 2009-07-22 2015-01-28 씨제이제일제당 주식회사 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물
KR101178217B1 (ko) 2009-10-28 2012-09-07 씨제이제일제당 (주) 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물
EP2332557A1 (de) 2009-12-08 2011-06-15 Campina Nederland Holding B.V. Probiotische Milchsäurebakterien
KR101127268B1 (ko) 2009-12-16 2012-03-29 박치호 알레르기성 비염 개선용 건강식품 조성물
TWI418356B (zh) * 2009-12-23 2013-12-11 Lytone Enterprise Inc 可作為免疫調節劑之副乾酪乳酸桿菌ｌｔ１２
US8372392B2 (en) * 2009-12-23 2013-02-12 Lytone Enterprise, Inc. Lactobacillus paracasei strain LT12 as immunity regulatory agent
WO2011111734A1 (ja) 2010-03-10 2011-09-15 株式会社カネカ 乳酸菌含有製剤
JP4942831B2 (ja) * 2010-03-19 2012-05-30 株式会社キティー 抗アレルギー用組成物
JP5592682B2 (ja) * 2010-03-26 2014-09-17 株式会社明治 少容量に充填したプロバイオティクス含有組成物
US8980289B2 (en) 2010-08-31 2015-03-17 Niigata University Intestine immunomodulator
JP6020981B2 (ja) * 2010-10-15 2016-11-02 国立研究開発法人農業・食品産業技術総合研究機構 カテコールアミン認識性を指標に選抜した微生物とカテコールアミン含有組成物
US11235008B2 (en) 2011-03-31 2022-02-01 Ganeden Biotech, Inc. Probiotic sports nutrition compositions
JP5801084B2 (ja) * 2011-03-31 2015-10-28 森永乳業株式会社 乳酸菌含有飲食品を加熱殺菌する方法、及び加熱処理における乳酸菌の免疫賦活活性の低下を抑制する方法
JP6124275B2 (ja) * 2011-03-31 2017-05-10 国立研究開発法人農業・食品産業技術総合研究機構 グアイアコール認識性を指標に選抜した微生物と微生物増殖促進活性を有するグアイアコール含有組成物
WO2012133827A1 (ja) * 2011-03-31 2012-10-04 森永乳業株式会社 新規乳酸菌、並びに新規乳酸菌を含有する医薬、飲食品、及び飼料
JP6230050B2 (ja) * 2013-10-09 2017-11-15 国立研究開発法人農業・食品産業技術総合研究機構 消化管粘膜付着性を有する乳酸菌
US9587284B2 (en) * 2014-02-21 2017-03-07 Asian Probiotics and Prebiotics Ltd. Lactic acid bacterium having immunomodulatory and anti-allergic effects and pharmaceutical composition containing the same
JP6486612B2 (ja) * 2014-05-27 2019-03-20 株式会社山田養蜂場本社 抗アレルギー作用を有する乳酸菌及びその用途
MA41020A (fr) 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
KR102534934B1 (ko) 2015-06-01 2023-05-19 사이세이 파마 씨오., 엘티디. 우유 효소 처리물, 그 제조 방법, 조성물 및 제품
CN106262931A (zh) * 2016-08-04 2017-01-04 吉林省农业科学院 植物乳杆菌在制备抗过敏产品中的应用
JP6815139B2 (ja) * 2016-09-09 2021-01-20 キリンホールディングス株式会社 乳酸菌を有効成分とする加齢による網膜細胞死を抑制するための組成物
US11389494B2 (en) 2016-09-09 2022-07-19 Kirin Holdings Kabushiki Kaisha Composition for suppressing or improving eye fatigue
JP6942030B2 (ja) * 2017-11-02 2021-09-29 株式会社ヤクルト本社 抗アレルギー剤感受性判定マーカー
JP7117853B2 (ja) * 2018-01-17 2022-08-15 アサヒ飲料株式会社 容器詰めコーヒー飲料及び容器詰めコーヒー飲料の味質改善方法
TWI746955B (zh) * 2018-04-25 2021-11-21 日商曾根農場股份有限公司 第i型過敏用組成物
TWI727293B (zh) * 2018-04-25 2021-05-11 日商曾根農場股份有限公司 第iv型過敏用組成物
US12491248B2 (en) * 2019-12-20 2025-12-09 Therakos Development Limited Method for generating immunoregulatory cells in a blood-derived sample
EP4090165A4 (de) * 2020-01-16 2024-01-24 National University of Singapore Kaffeebasiertes getränk
WO2025084295A1 (ja) * 2023-10-17 2025-04-24 キリンホールディングス株式会社 乳酸菌含有麦茶飲料
WO2025134440A1 (ja) * 2023-12-22 2025-06-26 キリンビバレッジ株式会社 芳醇感の増強された飲料及びその製造方法、並びに飲料の芳醇感の増強方法
JP7737588B1 (ja) * 2023-12-22 2025-09-10 キリンホールディングス株式会社 飲料及びその製造方法、並びに飲料の異臭マスキング方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH092959A (ja) * 1995-06-16 1997-01-07 Yakult Honsha Co Ltd ＩｇＥ抗体産生抑制剤および抗アレルギー剤
JP4064480B2 (ja) * 1996-10-11 2008-03-19 ハウスウェルネスフーズ株式会社 ＩｇＧ抗体産生抑制剤
JPH10309178A (ja) * 1997-05-09 1998-11-24 Wakamoto Pharmaceut Co Ltd ビフィズス菌を有効成分とする抗アレルギー剤および醗酵食品
SE510813C2 (sv) * 1997-12-08 1999-06-28 Arla Ekonomisk Foerening Bakteriestam av arten Lactobacillus Paracasei subsp. paracasei, sammansättning därav för användning i livsmedel, samt produkt innehållande stammen
JP4064515B2 (ja) * 1998-02-13 2008-03-19 ハウスウェルネスフーズ株式会社 Ｉｌ−１２産生誘導組成物
AU4059999A (en) * 1998-06-05 1999-12-30 Wakamoto Pharmaceutical Co., Ltd. Lactic acid bacterium-containing compositions, drugs and foods
EP1034788A1 (de) * 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Milchsäure Bakterienstämme zur Verhinderung von Diarrhöe
EP1034787A1 (de) * 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus Stämme die gegen pathogenische Bacteria veranlassende Diarrhöe schutzen
AUPQ415899A0 (en) * 1999-11-19 1999-12-16 Vasse Research Institute Pty Ltd Compositions for and methods of treatment of allergic diseases
JP4603116B2 (ja) * 1999-12-02 2010-12-22 わかもと製薬株式会社 乳酸菌含有組成物、医薬及び食品
EP1296693A4 (de) * 2000-06-19 2005-05-25 Mucoprotec Pty Ltd Immunotherapie sowie verbindungen mit probiotika zur behandlung bakterieller oder viraler infektionen an mukosalen oberflächen
SE0003100D0 (sv) * 2000-09-01 2000-09-01 Probi Ab New strains
WO2002028402A1 (en) * 2000-10-06 2002-04-11 Société des Produits Nestlé S.A. Use of probiotic lactic acid bacteria for balancing the skin's immune system
KR100356672B1 (ko) * 2001-12-27 2002-10-19 주식회사 바이로박트 신규한 락토바실러스 속 미생물 및 그 용도
EP1364586A1 (de) * 2002-05-24 2003-11-26 Nestec S.A. Probiotika und Oraltoleranz
JP4308481B2 (ja) * 2002-06-18 2009-08-05 独立行政法人農業・食品産業技術総合研究機構 抗アレルギー剤
TWI277651B (en) * 2002-09-02 2007-04-01 Genmont Biotech Inc New use of some lactobacillus strains in treating allergy
JP4034632B2 (ja) * 2002-10-01 2008-01-16 ハウスウェルネスフーズ株式会社 乳酸菌含有炊飯用組成物
JP2004267292A (ja) * 2003-03-05 2004-09-30 Sekisui Life-Tec Co Ltd ボトル状容器の水切り用具
EP1759597B1 (de) * 2003-03-13 2009-01-21 Kirin Holdings Kabushiki Kaisha Probiotische Zusammensetzung

Also Published As

Publication number Publication date
TWI324068B (en) 2010-05-01
CN1767839A (zh) 2006-05-03
KR20050109985A (ko) 2005-11-22
TW200500074A (en) 2005-01-01
EP1759597A2 (de) 2007-03-07
US20060088513A1 (en) 2006-04-27
AU2004233658B2 (en) 2009-10-29
JP2005139160A (ja) 2005-06-02
ES2320920T3 (es) 2009-05-29
EP1759597A3 (de) 2007-03-28
KR100908254B1 (ko) 2009-07-20
AU2004233658A1 (en) 2004-11-11
EP1634600A4 (de) 2007-03-14
HK1090289A1 (en) 2006-12-22
CA2518947A1 (en) 2004-11-11
JPWO2004096246A1 (ja) 2006-07-13
CN1767839B (zh) 2012-08-22
WO2004096246A1 (ja) 2004-11-11
EP1759597B1 (de) 2009-01-21
JP3585487B1 (ja) 2004-11-04
JP2005137357A (ja) 2005-06-02
EP1634600A1 (de) 2006-03-15
DE602004019255D1 (de) 2009-03-12

Similar Documents

Publication Publication Date Title
DE602004019255D1 (de) Probiotische Zusammensetzung
EP4257194A3 (de) Verwendung von mikrobiellen gemeinschaften für human- und tiergesundheit
WO2009138091A3 (en) Isolated microorganism strain lactobacillus plantarum tensia dsm 21380 as antimicrobial and antihypertensive probiotic, food product and composition comprising said microorganism and use of said microorganism for preparation of antihypertensive medicine and method for suppressing pathogens and non-starter lactobacilli in food product
ATE297664T1 (de) Probiotika-kombination
WO2003033681A3 (en) Composition comprising a lactobacillus pentosus strain and uses thereof
SE0402406D0 (sv) Probiotic lactobacillus strains for improved vaginal health
TW200514847A (en) Lactic acid bacteria having mucosal immunopotentiation effect
RU2010147343A (ru) ИЗОЛИРОВАННЫЙ ШТАММ МИКРООРГАНИЗМА Lactobacillus plantarum Inducia DSM 21379 В КАЧЕСТВЕ ПРОБИОТИКА, УСИЛИВАЮЩЕГО ВРОЖДЕННЫЙ ИММУНИТЕТ ОРГАНИЗМА, ПРОДУКТ И КОМПОЗИЦИЯ, СОДЕРЖАЩИЕ УПОМОМЯНУТЫЙ МИКРООРГАНИЗМ, И ПРИМЕНЕНИЕ УПОМЯНУТОГО МИКРООРГАНИЗМА ДЛЯ ИЗГОТОВЛЕНИЯ ЛЕКАРСТВЕННОГО СРЕДСТВА, КОТОРОЕ УСИЛИВАЕТ КЛЕТОЧНЫЙ ИММУНИТЕТ
UA93911C2 (ru) Применение бактериального штамма lactobacillus reuteri dsm 17938 для снижения колик у грудных детей
WO2003080813A3 (en) Lactobacillus strains
WO2005110445A3 (en) Methods and compositions for the dietary management of autoimmune disorders
WO2012149615A3 (en) Polybacterial preparation with health benefits: antioxidant effect, reduction of cholesterol concentration, anti-inflammatory immunomodulating effect and release of bioactive peptides inhibiting angiotensin-converting enzyme
MY127895A (en) New lactic acid bacteria strains capable of preventing diarrhoea
ZA200500715B (en) Antiallergic agent, utilization thereof for reducing allergy and method of reducing allergy
DE69839993D1 (de) Probiotisches milchsäurebakterium zur behandlung bakterieller infektionen in zusammenhang mit sids
ATE367821T1 (de) Folsäure produzierende bifidobacterium bakterienstämme, ihre formulierungen und verwendung
FI20075539A0 (fi) Maitohappobakteerit, joilla on proinflammatorisia ominaisuuksia
TW200700074A (en) Inducer of t cell apoptosis
DE602005018237D1 (de) Zusammensetzung mit immunregulierenden wirkungen aus lactobacillus pentosus
WO2004087891A8 (en) Lactobacillus fermentum strain and uses thereof
WO2007015132A3 (en) Use of specific lactic bacteria for the preparation of immunomodulating compositions
FI20002445A0 (fi) Menetelmä bakteerien seulomiseksi
ATE291353T1 (de) Verwendung von milchsaürebakterien bei der herstellung von fermentierten milchprodukten zur behandlung von verringerten immunitätsebenen
GEU20061256Y (en) Yoghurt
TH83780B (th) สารผสมที่มีหน้าที่ควบคุมการตอบสนองทางภูมิคุ้มกัน

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties